āĻšā§āĻŽVTRS âĸ NASDAQ
add
Viatris Inc
ā§Ž.ā§ā§§$
āĻāĻŖā§āĻāĻž āĻĒāϰā§:(ā§§.⧍ā§Ŧ%)-ā§Ļ.ā§§ā§§
ā§Ž.ā§Ŧā§Ļ$
āĻŦāύā§āϧ āĻāĻā§: ā§Ŧ āĻā§āύ, ā§Ģ:ā§Ģ⧍:ā§Šā§Ģ PM GMT -ā§Ē · USD · NASDAQ · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āϏā§āĻāĻāĻŽāĻžāϰā§āĻāĻŋāύ āϝā§āĻā§āϤāϰāĻžāώā§āĻā§āϰ-āĻ āϤāĻžāϞāĻŋāĻāĻžāĻā§āĻā§āϤ āϏāĻŋāĻāĻŋāĻāϰāĻŋāĻāĻŋāĻŽāĻžāϰā§āĻāĻŋāύ āϝā§āĻā§āϤāϰāĻžāώā§āĻā§āϰ-āĻ āĻšā§āĻĄāĻā§ā§āĻžāϰā§āĻāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§Ž.ā§Ēā§Ŧ$
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
ā§Ž.ā§Ģ⧍$ - ā§Ž.ā§ā§Š$
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§Ŧ.ā§Žā§Ģ$ - ā§§ā§Š.ā§Ģā§Ģ$
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
ā§§ā§Ļ.⧍⧍āĻļāĻ¤Â āĻā§ USD
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
ā§§.ā§Ŧā§Ŧ āĻā§
P/E āĻ
āύā§āĻĒāĻžāϤ
-
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
ā§Ģ.ā§Ģā§§%
āĻĒā§āϰāĻžāĻāĻŽāĻžāϰāĻŋ āĻāĻā§āϏāĻā§āĻā§āĻ
NASDAQ
āĻāĻŦāϰ⧠āϰā§ā§āĻā§
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
(USD) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ā§Šā§¨ā§Ģ.ā§Ēā§ŠÂ āĻā§ | -ā§§ā§§.ā§§ā§% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§§ā§Ļā§Ģ.ā§Ļā§¨Â āĻā§ | -ā§Ŧ.ā§Ļ⧍% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | -ā§Šā§Ļā§Ē.⧍ā§Ļ āĻā§ | -⧍,ā§ā§ā§Ļ.ā§ā§Ŧ% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | -ā§¯ā§Š.ā§Ēā§Ž | -ā§Š,ā§§ā§Ļā§Ģ.ā§ā§¯% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | ā§Ļ.ā§Ģā§Ļ | -⧍ā§Ģ.ā§Šā§% |
EBITDA | ā§Žā§Ē.ā§¯ā§ŠÂ āĻā§ | -ā§¨ā§Š.⧝ā§Ļ% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ā§§.ā§ā§Ž% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(USD) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§§ā§Ļā§Ļ.ā§¨ā§¨Â āĻā§ | -⧝.ā§Šā§Ē% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§Šā§Ž.ā§Ēā§āĻļāĻ¤Â āĻā§ | -ā§§ā§Ž.ā§ā§Š% |
āĻŽā§āĻ āĻĻāĻžā§ | ⧍⧍.ā§Žā§¨āĻļāĻ¤Â āĻā§ | -ā§§ā§Ŧ.ā§Ēā§Ž% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§§ā§Ģ.ā§Ŧā§ĢāĻļāĻ¤Â āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§§ā§§ā§.ā§Šā§Â āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§Ļ.ā§Ŧā§Ē | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§§.ā§§ā§Ģ% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | ā§§.ā§Ēā§Ŧ% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
(USD) | āĻŽāĻžāϰā§āĻ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | -ā§Šā§Ļā§Ē.⧍ā§Ļ āĻā§ | -⧍,ā§ā§ā§Ļ.ā§ā§Ŧ% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | ā§Ģā§Š.ā§Ģā§Ģ āĻā§ | -⧧⧍.ā§Žā§% |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§Ŧ.ā§Ģā§§Â āĻā§ | ā§Ģā§.ā§Žā§§% |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§Ēā§Ŧ.ā§ā§Ļ āĻā§ | -⧝.ā§ā§Š% |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | ⧍.ā§Ļā§¨Â āĻā§ | -⧝.ā§Ē⧍% |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| ā§Ē⧍.ā§§ā§ŽÂ āĻā§ | -ā§Ģā§Ļ.ā§Žā§Ŧ% |
āϏāĻŽā§āĻĒāϰā§āĻā§
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community.
Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue. Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
ā§§ā§Ŧ āύāĻā§, ⧍ā§Ļ⧍ā§Ļ
āϏāĻĻāϰ āĻĻāĻĒā§āϤāϰ
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§Šā§¨,ā§Ļā§Ļā§Ļ